LW
AZN icon

Linscomb Wealth’s AstraZeneca AZN Stock Holding History

Linscomb Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,453
Closed -$220K – 264
2015
Q2 		$220K Buy
3,453
+170
+5% +$11.6K 0.02% 248
2015
Q1 		$225K Sell
3,283
-1,173
-26% -$81.5K 0.02% 246
2014
Q4 		$314K Sell
4,456
-678
-13% -$48.5K 0.03% 213
2014
Q3 		$367K Sell
5,134
-332
-6% -$24.3K 0.04% 200
2014
Q2 		$406K Sell
5,466
-486
-8% -$35.1K 0.04% 188
2014
Q1 		$386K Buy
5,952
+111
+2% +$7.17K 0.04% 188
2013
Q4 		$347K Sell
5,841
-1,050
-15% -$57K 0.04% 168
2013
Q3 		$358K Sell
6,891
-599
-8% -$30.1K 0.05% 165
2013
Q2 		$354K Buy
+7,490
New +$381K 0.05% 164

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Linscomb Wealth's AZN Position: Q3 2015 in Review

Linscomb Wealth sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 3,453 shares — an estimated $220K sold.

Linscomb Wealth first reported a position in AZN in Q2 2013 and held it in 9 quarters. The position peaked at $406K in Q2 2014. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

  • Linscomb Wealth reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
  • Linscomb Wealth sold 3,453 AstraZeneca shares in Q3 2015, an estimated $220K.
  • Linscomb Wealth first reported a position in AstraZeneca in Q2 2013 and held it in 9 quarters.
  • Linscomb Wealth's AstraZeneca position peaked at $406K in Q2 2014.
  • 371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on Linscomb Wealth's 13F filing for Q3 2015, filed 9 Nov 2015.